The GMO Quarterly Letter (Q4 2024), authored by Ben Inker and Anna Chetoukhina, analyzes underperforming equity markets and outlines investment opportunities.
• U.S. Large Value Equities: Among the cheapest in history, poised for potential outperformance with controlled stock-specific risks.
• U.S. Small Caps: Inexpensive but facing headwinds like deteriorating profitability and rising leverage; high-quality small caps are preferable.
• China: Offers low valuations but suffers from weakening fundamentals and geopolitical risks, favoring other emerging markets.
Explore the detailed analysis and actionable insights in the full report to navigate the evolving investment landscape effectively.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
